Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00186433
Status:
COMPLETED
Last Update Posted:
2015-05-27
First Post:
2005-09-13
Brief Title:
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 To determine the prognostic implication of plasma Epstein-Bar Virus EBV DNA concentrations as measured by quantitative polymerase chain reaction PCR in patients with nasopharyngeal carcinoma NPC
2 To relate pretreatment plasma EBV DNA concentration to WHO classification of these tumors both in endemic and non-endemic areas
3 To determine whether pretreatment plasma EBV DNA can serve as a prognostic factor for both endemic and non-endemic patient populations
2 To relate pretreatment plasma EBV DNA concentration to WHO classification of these tumors both in endemic and non-endemic areas
3 To determine whether pretreatment plasma EBV DNA can serve as a prognostic factor for both endemic and non-endemic patient populations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 77622 | OTHER | Stanford University Alternate IRB Approval Number | None |
| ENT0006 | OTHER | None | None |